136 related articles for article (PubMed ID: 34927983)
21. Functionalized mesoporous silica nanoparticles with redox-responsive short-chain gatekeepers for agrochemical delivery.
Yi Z; Hussain HI; Feng C; Sun D; She F; Rookes JE; Cahill DM; Kong L
ACS Appl Mater Interfaces; 2015 May; 7(18):9937-46. PubMed ID: 25902154
[TBL] [Abstract][Full Text] [Related]
22. Charge-Selective Delivery of Proteins Using Mesoporous Silica Nanoparticles Fused with Lipid Bilayers.
Shi H; Liu S; Cheng J; Yuan S; Yang Y; Fang T; Cao K; Wei K; Zhang Q; Liu Y
ACS Appl Mater Interfaces; 2019 Jan; 11(4):3645-3653. PubMed ID: 30609348
[TBL] [Abstract][Full Text] [Related]
23. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
24. Hydrolytic surface erosion of mesoporous silica nanoparticles for efficient intracellular delivery of cytochrome c.
Choi E; Lim DK; Kim S
J Colloid Interface Sci; 2020 Feb; 560():416-425. PubMed ID: 31679782
[TBL] [Abstract][Full Text] [Related]
25. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
26. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
28. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
[TBL] [Abstract][Full Text] [Related]
29. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
30. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
Slowing II; Vivero-Escoto JL; Wu CW; Lin VS
Adv Drug Deliv Rev; 2008 Aug; 60(11):1278-1288. PubMed ID: 18514969
[TBL] [Abstract][Full Text] [Related]
31. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
[TBL] [Abstract][Full Text] [Related]
32. A diatom-based biohybrid microrobot with a high drug-loading capacity and pH-sensitive drug release for target therapy.
Li M; Wu J; Lin D; Yang J; Jiao N; Wang Y; Liu L
Acta Biomater; 2022 Dec; 154():443-453. PubMed ID: 36243369
[TBL] [Abstract][Full Text] [Related]
33. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
34. Gastro-protective protein-silica nanoparticles formulation for oral drug delivery: In vitro release, cytotoxicity and mitochondrial activity.
Juère E; Del Favero G; Masse F; Marko D; Popat A; Florek J; Caillard R; Kleitz F
Eur J Pharm Biopharm; 2020 Jun; 151():171-180. PubMed ID: 32302657
[TBL] [Abstract][Full Text] [Related]
35. A facile strategy to fabricate a pH-responsive mesoporous silica nanoparticle end-capped with amphiphilic peptides by self-assembly.
Zhao F; Zhang C; Zhao C; Gao W; Fan X; Wu G
Colloids Surf B Biointerfaces; 2019 Jul; 179():352-362. PubMed ID: 30991215
[TBL] [Abstract][Full Text] [Related]
36. ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy.
N VR; Han HS; Lee H; Nguyen VQ; Jeon S; Jung DW; Lee J; Yi GR; Park JH
Nanoscale; 2018 May; 10(20):9616-9627. PubMed ID: 29756137
[TBL] [Abstract][Full Text] [Related]
37. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
38. Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release.
Lai J; Shah BP; Garfunkel E; Lee KB
ACS Nano; 2013 Mar; 7(3):2741-50. PubMed ID: 23445171
[TBL] [Abstract][Full Text] [Related]
39. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
Yuan X; Peng S; Lin W; Wang J; Zhang L
J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
[TBL] [Abstract][Full Text] [Related]
40. Layer-by-Layer (LBL) Self-Assembled Biohybrid Nanomaterials for Efficient Antibacterial Applications.
Wu Y; Long Y; Li QL; Han S; Ma J; Yang YW; Gao H
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17255-63. PubMed ID: 26192024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
